GLP-1 & The Total Rewards Budget

GLP-1 medications are no longer just a benefits question — they are a total rewards, budget, talent, and legal issue that every HR and compensation professional needs to be prepared to address. MorganHR's CompAware GLP-1 Talking Points Guide delivers practical, audience-specific guidance built for real workplace conversations. Inside: a plain-language primer on glucagon-like peptide-1 (GLP-1) drug classes and FDA-approved indications; employer coverage benchmarks from KFF, Mercer, PHTI, and IFEBP; a plan design comparison table with 2026 prevalence data; equity, ADA, HIPAA, and state mandate considerations; employee Q&A scripts and ready-to-use communication templates for both adding and restricting coverage; dedicated small employer guidance for fully insured and level-funded plans; a sourced 2026 mid-year reality check; and a 2027 price and competition outlook. Developed by MorganHR, Inc. — a compensation consulting firm with four decades of total rewards expertise and the publisher of The Decoder Ring labor market intelligence report.